MoneyWorks4Me

Lasa Supergenerics - Quaterly Results

28 May 2025 Evaluate
The Turnover for the quarter ended March 2025 of Rs. 391.38 millions increase by 71.54% from Rs. 228.16 millions.The Net Loss for the quarter ended March 2025 is Rs. -142.92 millions as compared to Net Loss of Rs. -153.00 millions of corresponding quarter ended March 2024 Operating profit Margin for the quarter ended March 2025 improved to 58.03% as compared to -39.73% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 391.38 228.16 71.54 1424.48 1043.35 36.53 1424.48 1043.35 36.53
Other Income 23.92 0.09 26477.78 50.12 1.02 4813.73 50.12 1.02 4813.73
PBIDT 58.03 -39.73 -246.06 112.77 22.64 398.10 112.77 22.64 398.10
Interest 1.08 5.60 -80.71 26.92 19.32 39.34 26.92 19.32 39.34
PBDT -182.19 -133.06 36.92 -70.84 -84.41 -16.08 -70.84 -84.41 -16.08
Depreciation 38.99 26.61 46.52 123.00 106.73 15.24 123.00 106.73 15.24
PBT -221.18 -159.67 38.52 -193.84 -191.14 1.41 -193.84 -191.14 1.41
TAX -78.26 -6.67 1073.31 -46.26 26.18 -276.70 -46.26 26.18 -276.70
Deferred Tax -78.26 -6.67 1073.31 -46.26 26.18 -276.70 -46.26 26.18 -276.70
PAT -142.92 -153.00 -6.59 -147.58 -217.32 -32.09 -147.58 -217.32 -32.09
Equity 501.01 501.01 0.00 501.01 501.01 0.00 501.01 501.01 0.00
PBIDTM(%) 14.83 -17.41 -185.15 7.92 2.17 264.84 7.92 2.17 264.84
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..